Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $408.48 million. The enterprise value is $158.13 million.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CTKB has 126.66 million shares outstanding. The number of shares has decreased by -3.11% in one year.
Current Share Class | 126.66M |
Shares Outstanding | 126.66M |
Shares Change (YoY) | -3.11% |
Shares Change (QoQ) | -0.57% |
Owned by Insiders (%) | 9.24% |
Owned by Institutions (%) | 56.40% |
Float | 108.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 128.80 |
PS Ratio | 2.12 |
Forward PS | 1.95 |
PB Ratio | 1.08 |
P/TBV Ratio | 1.19 |
P/FCF Ratio | 23.32 |
P/OCF Ratio | 19.15 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.80 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 9.04 |
Financial Position
The company has a current ratio of 5.62, with a Debt / Equity ratio of 0.04.
Current Ratio | 5.62 |
Quick Ratio | 4.74 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | 0.91 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.91% and return on invested capital (ROIC) is -4.26%.
Return on Equity (ROE) | -2.91% |
Return on Assets (ROA) | -3.51% |
Return on Invested Capital (ROIC) | -4.26% |
Return on Capital Employed (ROCE) | -6.60% |
Revenue Per Employee | $304,090 |
Profits Per Employee | -$17,366 |
Employee Count | 648 |
Asset Turnover | 0.40 |
Inventory Turnover | 1.77 |
Taxes
In the past 12 months, CTKB has paid $3.28 million in taxes.
Income Tax | 3.28M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.90% in the last 52 weeks. The beta is 1.26, so CTKB's price volatility has been higher than the market average.
Beta (5Y) | 1.26 |
52-Week Price Change | -47.90% |
50-Day Moving Average | 3.32 |
200-Day Moving Average | 4.97 |
Relative Strength Index (RSI) | 51.28 |
Average Volume (20 Days) | 1,515,988 |
Short Selling Information
The latest short interest is 5.41 million, so 4.27% of the outstanding shares have been sold short.
Short Interest | 5.41M |
Short Previous Month | 4.65M |
Short % of Shares Out | 4.27% |
Short % of Float | 5.00% |
Short Ratio (days to cover) | 5.27 |
Income Statement
In the last 12 months, CTKB had revenue of $197.05 million and -$11.25 million in losses. Loss per share was -$0.09.
Revenue | 197.05M |
Gross Profit | 108.25M |
Operating Income | -27.36M |
Pretax Income | -16.25M |
Net Income | -11.25M |
EBITDA | -19.98M |
EBIT | -27.36M |
Loss Per Share | -$0.09 |
Full Income Statement Balance Sheet
The company has $265.61 million in cash and $15.90 million in debt, giving a net cash position of $249.72 million or $1.97 per share.
Cash & Cash Equivalents | 265.61M |
Total Debt | 15.90M |
Net Cash | 249.72M |
Net Cash Per Share | $1.97 |
Equity (Book Value) | 379.62M |
Book Value Per Share | 2.98 |
Working Capital | 312.81M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $21.30 million and capital expenditures -$3.81 million, giving a free cash flow of $17.49 million.
Operating Cash Flow | 21.30M |
Capital Expenditures | -3.81M |
Free Cash Flow | 17.49M |
FCF Per Share | $0.14 |
Full Cash Flow Statement Margins
Gross margin is 54.94%, with operating and profit margins of -13.89% and -5.71%.
Gross Margin | 54.94% |
Operating Margin | -13.89% |
Pretax Margin | -4.05% |
Profit Margin | -5.71% |
EBITDA Margin | -10.14% |
EBIT Margin | -13.89% |
FCF Margin | 8.88% |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 3.11% |
Shareholder Yield | 3.11% |
Earnings Yield | -2.76% |
FCF Yield | 4.29% |
Analyst Forecast
The average price target for CTKB is $6.00, which is 86.05% higher than the current price. The consensus rating is "Hold".
Price Target | $6.00 |
Price Target Difference | 86.05% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 5.2 and a Piotroski F-Score of 4.
Altman Z-Score | 5.2 |
Piotroski F-Score | 4 |